Marvin J Fritzler Selected Research

Raynaud Disease (Raynaud's Disease)

1/2017	Prevalence of Systemic Sclerosis in Primary Biliary Cholangitis Using the New ACR/EULAR Classification Criteria.
11/2014	An autoimmune myositis-overlap syndrome associated with autoantibodies to nuclear pore complexes: description and long-term follow-up of the anti-Nup syndrome.
5/2010	Systemic sclerosis: establishing diagnostic criteria.
2/2009	B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marvin J Fritzler Research Topics

Disease

46	Systemic Scleroderma (Systemic Sclerosis) 10/2022 - 12/2003
27	Autoimmune Diseases (Autoimmune Disease) 10/2022 - 01/2002
26	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2022 - 01/2002
24	Rheumatic Diseases (Rheumatism) 01/2021 - 12/2003
17	Myositis (Idiopathic Inflammatory Myopathies) 10/2022 - 01/2007
17	Rheumatoid Arthritis 10/2022 - 12/2003
13	Neoplasms (Cancer) 01/2022 - 01/2006
9	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2022 - 03/2012
9	Infections 03/2022 - 09/2003
9	Muscular Diseases (Myopathy) 01/2022 - 10/2016
9	Arthritis (Polyarthritis) 01/2021 - 01/2002
8	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2022 - 01/2005
7	Disease Progression 05/2021 - 01/2003
6	COVID-19 01/2022 - 01/2021
6	Polymyositis 12/2021 - 06/2003
5	Connective Tissue Diseases (Connective Tissue Disease) 06/2022 - 06/2003
5	Calcinosis 01/2020 - 02/2011
4	Necrosis 01/2019 - 01/2002
4	Raynaud Disease (Raynaud's Disease) 01/2017 - 02/2009
3	Autoimmune Hepatitis 10/2022 - 01/2018
3	Pneumonia (Pneumonitis) 01/2022 - 01/2019
3	Dermatomyositis (Dermatopolymyositis) 12/2021 - 06/2014
3	Inflammation (Inflammations) 01/2021 - 04/2012
3	Lung Diseases (Lung Disease) 01/2021 - 04/2012
3	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 09/2020 - 01/2012
3	Ulcerative Colitis 09/2020 - 09/2013
3	Ataxia (Dyssynergia) 08/2019 - 09/2003
3	Fibrosis (Cirrhosis) 01/2018 - 02/2009
3	Membranous Glomerulonephritis (Membranous Nephropathy) 08/2014 - 01/2013
3	Telangiectasis (Telangiectasia) 02/2011 - 08/2005
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2022 - 01/2021
2	Confusion (Bewilderment) 06/2022 - 11/2007
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 06/2022 - 11/2014
2	Uveitis 06/2022 - 12/2015
2	Muscle Weakness 02/2022 - 01/2019
2	Critical Illness (Critically Ill) 11/2021 - 01/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2020 - 01/2014
2	Liver Diseases (Liver Disease) 09/2020 - 06/2018
2	Nephritis 09/2020 - 06/2010
2	Crohn Disease (Crohn's Disease) 09/2020 - 09/2013
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2017 - 11/2004
2	Asthma (Bronchial Asthma) 08/2016 - 11/2012
2	Breast Neoplasms (Breast Cancer) 02/2016 - 01/2013
2	Pemphigus (Pemphigus Vulgaris) 01/2016 - 03/2009
2	Diffuse Scleroderma (Progressive Systemic Sclerosis) 01/2016 - 02/2009
2	Osteoarthritis 08/2014 - 08/2013
2	Proteinuria 08/2014 - 12/2004
2	Astrocytoma (Pilocytic Astrocytoma) 10/2010 - 12/2007
2	Polyneuropathies (Polyneuropathy) 12/2003 - 01/2003

Drug/Important Bio-Agent (IBA)

97	AutoantibodiesIBA 10/2022 - 01/2002
60	AntibodiesIBA 06/2022 - 09/2003
28	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2006
21	Antinuclear AntibodiesIBA 06/2022 - 11/2007
13	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2004
11	AutoantigensIBA 01/2021 - 01/2002
11	AntigensIBA 09/2020 - 09/2003
8	Anti-Citrullinated Protein AntibodiesIBA 01/2021 - 01/2008
8	Peptides (Polypeptides)IBA 01/2021 - 01/2005
6	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2022 - 01/2007
6	EpitopesIBA 03/2018 - 01/2005
5	CytokinesIBA 01/2022 - 06/2012
5	RNA Polymerase IIIIBA 01/2022 - 07/2007
5	Immunoglobulin G (IgG)IBA 01/2021 - 04/2012
4	InterferonsIBA 01/2022 - 03/2013
4	fibrillarinIBA 01/2022 - 11/2004
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 10/2016
4	MicroRNAs (MicroRNA)IBA 08/2015 - 01/2006
4	Messenger RNA (mRNA)IBA 08/2015 - 12/2004
3	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2003
3	Immunoglobulin M (IgM)IBA 01/2021 - 06/2011
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2020 - 09/2013
3	Pharmaceutical PreparationsIBA 09/2020 - 11/2014
3	EnzymesIBA 01/2019 - 01/2006
3	Oxidoreductases (Dehydrogenase)IBA 01/2017 - 10/2016
3	Coenzyme A (CoA)IBA 01/2017 - 10/2016
3	Phospholipase A2 ReceptorsIBA 08/2014 - 01/2013
3	anticentromere antibodyIBA 10/2011 - 09/2007
3	trioctyl phosphine oxide (TOPO)IBA 09/2010 - 11/2004
2	Creatine Kinase (Creatine Phosphokinase)IBA 02/2022 - 01/2017
2	Signal Recognition ParticleIBA 01/2022 - 01/2017
2	Antiphospholipid AntibodiesIBA 11/2021 - 01/2021
2	AsbestosIBA 01/2021 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2014
2	Histones (Histone)IBA 01/2021 - 01/2014
2	SMN Complex ProteinsIBA 01/2020 - 01/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 11/2014
2	ImmunosorbentsIBA 01/2019 - 01/2016
2	Rituximab (Mabthera)FDA Link 01/2019 - 02/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 01/2016
2	Antiviral Agents (Antivirals)IBA 06/2018 - 03/2013
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2017 - 12/2016
2	early endosome antigen 1IBA 01/2016 - 06/2003
2	Rheumatoid FactorIBA 11/2014 - 04/2012
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2014 - 11/2007
2	Immunoglobulins (Immunoglobulin)IBA 01/2014 - 12/2004
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2012 - 01/2007
2	RibonucleoproteinsIBA 06/2010 - 01/2005
2	PhosphoproteinsIBA 01/2006 - 01/2003

Therapy/Procedure

4	Therapeutics 01/2018 - 11/2004
2	Lasers (Laser) 01/2021 - 02/2016